Germany's Stratec Biomedical Systems goes public
This article was originally published in Clinica
Executive Summary
The German company Stratec Biomedical Systems is to go public in order to raise capital for expansion. It will float 10% of its stock to potential investors and use the proceeds to develop its biotechnology division.